NGS Sequencing for COVID-19 drug development


Service description

  • Sequencing occurs at many stages of drug development.
  • In the case of the COVID-19 epidemic, sequencing of the SARS-CoV2 virus that has infected patients may assess whether it has mutated or not, and patient sequencing may be relevant to determine particular resistance or susceptibility.
  • NGS has also been used to identify variants of the virus, (like the delta variant or the omicron variant)
  • This service is designed for Biotech companies developing SARS-CoV-2 new drugs.

Materials to provide

  • Details about the request.
  • Samples to sequence.

  • Further details on the project may be requested.
  • You will be able to exchange directly with the experts after filling in the form below.

Typical deliverables

  • Sequencing following the specifications validated with the Expert.

Get started with your COVID-19 NGS sequencing analysis request

Please answer the fields below to be contacted by our team of scientists

COVID Labtoo 60
COVID-19 Services
Samples blood 60 2
Biological Samples
R&D mecanism 60
Experimental Services
favicon large un peu plus-1